Selected research
Industry Research
Equol Supplements Industry Research Report 2026
Market perspective
The global Equol Supplements market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Equol Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Equol Supplements is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Equol Supplements is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Equol Supplements include Advanced Medical Care Inc, AEON TOPVALU Co.,Ltd., BELTA Co., Ltd., DHC Corp., KURUKURU, Naris Cosmetics CO.,Ltd, Nutrined, ORIHIRO and seedcoms, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Equol Supplements market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Equol Supplements Market by Company
Advanced Medical Care Inc
AEON TOPVALU Co.,Ltd.
BELTA Co., Ltd.
DHC Corp.
KURUKURU
Naris Cosmetics CO.,Ltd
Nutrined
ORIHIRO
seedcoms
OTSUKA Phamaceutical Co.Ltd.
Kobayashi Pharmaceutical
Equol Supplements Segment by Type
Capsule
Tablet
Other
Equol Supplements Segment by Application
Online Sales
Offline Sales
Equol Supplements Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equol Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Equol Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Equol Supplements.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Equol Supplements manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Equol Supplements by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Equol Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsule
- Tablet
- Other
Applications
- Online Sales
- Offline Sales
Companies covered
- Advanced Medical Care Inc
- AEON TOPVALU Co.,Ltd.
- BELTA Co., Ltd.
- DHC Corp.
- KURUKURU
- Naris Cosmetics CO.,Ltd
- Nutrined
- ORIHIRO
- seedcoms
- OTSUKA Phamaceutical Co.Ltd.
- Kobayashi Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Equol Supplements Market Size (2021-2032)
- 2.2.2 Global Equol Supplements Sales (2021-2032)
- 2.2.3 Global Equol Supplements Market Average Price (2021-2032)
- 2.3 Equol Supplements by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Capsule
- 2.3.3 Tablet
- 2.3.4 Other
- 2.4 Equol Supplements by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Sales
- 2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Equol Supplements Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Equol Supplements Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Equol Supplements Revenue of Manufacturers (2021-2026)
- 3.4 Global Equol Supplements Average Price by Manufacturers (2021-2026)
- 3.5 Global Equol Supplements Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Equol Supplements, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Equol Supplements, Product Type & Application
- 3.8 Global Manufacturers of Equol Supplements, Established Date
- 3.9 Global Equol Supplements Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Advanced Medical Care Inc
- 4.1.1 Advanced Medical Care Inc Company Information
- 4.1.2 Advanced Medical Care Inc Business Overview
- 4.1.3 Advanced Medical Care Inc Equol Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Advanced Medical Care Inc Equol Supplements Product Portfolio
- 4.1.5 Advanced Medical Care Inc Recent Developments
- 4.2 AEON TOPVALU Co.,Ltd.
- 4.2.1 AEON TOPVALU Co.,Ltd. Company Information
- 4.2.2 AEON TOPVALU Co.,Ltd. Business Overview
- 4.2.3 AEON TOPVALU Co.,Ltd. Equol Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 AEON TOPVALU Co.,Ltd. Equol Supplements Product Portfolio
- 4.2.5 AEON TOPVALU Co.,Ltd. Recent Developments
- 4.3 BELTA Co., Ltd.
- 4.3.1 BELTA Co., Ltd. Company Information
- 4.3.2 BELTA Co., Ltd. Business Overview
- 4.3.3 BELTA Co., Ltd. Equol Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 BELTA Co., Ltd. Equol Supplements Product Portfolio
- 4.3.5 BELTA Co., Ltd. Recent Developments
- 4.4 DHC Corp.
- 4.4.1 DHC Corp. Company Information
- 4.4.2 DHC Corp. Business Overview
- 4.4.3 DHC Corp. Equol Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 DHC Corp. Equol Supplements Product Portfolio
- 4.4.5 DHC Corp. Recent Developments
- 4.5 KURUKURU
- 4.5.1 KURUKURU Company Information
- 4.5.2 KURUKURU Business Overview
- 4.5.3 KURUKURU Equol Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 KURUKURU Equol Supplements Product Portfolio
- 4.5.5 KURUKURU Recent Developments
- 4.6 Naris Cosmetics CO.,Ltd
- 4.6.1 Naris Cosmetics CO.,Ltd Company Information
- 4.6.2 Naris Cosmetics CO.,Ltd Business Overview
- 4.6.3 Naris Cosmetics CO.,Ltd Equol Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Naris Cosmetics CO.,Ltd Equol Supplements Product Portfolio
- 4.6.5 Naris Cosmetics CO.,Ltd Recent Developments
- 4.7 Nutrined
- 4.7.1 Nutrined Company Information
- 4.7.2 Nutrined Business Overview
- 4.7.3 Nutrined Equol Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Nutrined Equol Supplements Product Portfolio
- 4.7.5 Nutrined Recent Developments
- 4.8 ORIHIRO
- 4.8.1 ORIHIRO Company Information
- 4.8.2 ORIHIRO Business Overview
- 4.8.3 ORIHIRO Equol Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 ORIHIRO Equol Supplements Product Portfolio
- 4.8.5 ORIHIRO Recent Developments
- 4.9 seedcoms
- 4.9.1 seedcoms Company Information
- 4.9.2 seedcoms Business Overview
- 4.9.3 seedcoms Equol Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 seedcoms Equol Supplements Product Portfolio
- 4.9.5 seedcoms Recent Developments
- 4.10 OTSUKA Phamaceutical Co.Ltd.
- 4.10.1 OTSUKA Phamaceutical Co.Ltd. Company Information
- 4.10.2 OTSUKA Phamaceutical Co.Ltd. Business Overview
- 4.10.3 OTSUKA Phamaceutical Co.Ltd. Equol Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 OTSUKA Phamaceutical Co.Ltd. Equol Supplements Product Portfolio
- 4.10.5 OTSUKA Phamaceutical Co.Ltd. Recent Developments
- 4.11 Kobayashi Pharmaceutical
- 4.11.1 Kobayashi Pharmaceutical Company Information
- 4.11.2 Kobayashi Pharmaceutical Business Overview
- 4.11.3 Kobayashi Pharmaceutical Equol Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Kobayashi Pharmaceutical Equol Supplements Product Portfolio
- 4.11.5 Kobayashi Pharmaceutical Recent Developments
5 Global Equol Supplements Market Scenario by Region
- 5.1 Global Equol Supplements Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Equol Supplements Sales by Region: 2021-2032
- 5.2.1 Global Equol Supplements Sales by Region: 2021-2026
- 5.2.2 Global Equol Supplements Sales by Region: 2027-2032
- 5.3 Global Equol Supplements Revenue by Region: 2021-2032
- 5.3.1 Global Equol Supplements Revenue by Region: 2021-2026
- 5.3.2 Global Equol Supplements Revenue by Region: 2027-2032
- 5.4 North America Equol Supplements Market Facts & Figures by Country
- 5.4.1 North America Equol Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Equol Supplements Sales by Country (2021-2032)
- 5.4.3 North America Equol Supplements Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Equol Supplements Market Facts & Figures by Country
- 5.5.1 Europe Equol Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Equol Supplements Sales by Country (2021-2032)
- 5.5.3 Europe Equol Supplements Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Equol Supplements Market Facts & Figures by Country
- 5.6.1 Asia Pacific Equol Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Equol Supplements Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Equol Supplements Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Equol Supplements Market Facts & Figures by Country
- 5.7.1 South America Equol Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Equol Supplements Sales by Country (2021-2032)
- 5.7.3 South America Equol Supplements Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Equol Supplements Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Equol Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Equol Supplements Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Equol Supplements Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Equol Supplements Sales by Type (2021-2032)
- 6.1.1 Global Equol Supplements Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Equol Supplements Sales Market Share by Type (2021-2032)
- 6.2 Global Equol Supplements Revenue by Type (2021-2032)
- 6.2.1 Global Equol Supplements Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Equol Supplements Revenue Market Share by Type (2021-2032)
- 6.3 Global Equol Supplements Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Equol Supplements Sales by Application (2021-2032)
- 7.1.1 Global Equol Supplements Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Equol Supplements Sales Market Share by Application (2021-2032)
- 7.2 Global Equol Supplements Revenue by Application (2021-2032)
- 7.2.1 Global Equol Supplements Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Equol Supplements Revenue Market Share by Application (2021-2032)
- 7.3 Global Equol Supplements Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Equol Supplements Value Chain Analysis
- 8.1.1 Equol Supplements Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Equol Supplements Production Mode & Process
- 8.2 Equol Supplements Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Equol Supplements Distributors
- 8.2.3 Equol Supplements Customers
9 Global Equol Supplements Analyzing Market Dynamics
- 9.1 Equol Supplements Industry Trends
- 9.2 Equol Supplements Industry Drivers
- 9.3 Equol Supplements Industry Opportunities and Challenges
- 9.4 Equol Supplements Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst